TAK-071 in Parkinson Disease With Cognitive Impairment

🔗 Access full article via JAMA Neurology

This phase 2 randomized clinical trial evaluates the safety and efficacy of TAK-071 compared with placebo on gait and cognition in participants with Parkinson disease with a history of falls and cognitive impairment.